Abstracts Archive - Page 1397 of 2607 - ACR Meeting Abstracts

Abstract Number: 145 • 2017 ACR/ARHP Annual Meeting
Cause-Specific Mortality in a Large Population-Based Cohort of Rheumatoid Arthritis Patients in Italy
Francesca Ometto¹, UGO FEDELI², ELENA SCHIEVANO², Costantino Botsios³, MARIA CHIARA CORTI² and Leonardo Punzi⁴, ¹Rheumatology Unit, Department of Medicine - DIMED, University of Padova, PADOVA, Italy, ²Epidemiological Department, Veneto Region, VENETO, Italy, ³Rheumatology Unit, Department of Medicine - DIMED, University of Padova, Padova, Italy, ⁴Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy
Background/Purpose: Studies on mortality in RA from Italy are completely lacking. The aim of our study was to investigate cause-specific mortality in RA subjects living…
Abstract Number: 146 • 2017 ACR/ARHP Annual Meeting
Major Cardiovascular Events Among an Inception Cohort of Seniors with Rheumatoid Arthritis
Jessica Widdifield^1,2, Michael Paterson², Anjie Huang², Bindee Kuriya³, Carter Thorne⁴, Janet E. Pope⁵ and Sasha Bernatsky⁶, ¹Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, ON, Canada, ²Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ³Sinai Health System, University of Toronto, Toronto, ON, Canada, ⁴Southlake Regional Health Centre, Newmarket, ON, Canada, ⁵Department of Medicine, Division of Rheumatology, University of Western Ontario, St Joseph's Health Care, London, ON, Canada, ⁶Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: We previously observed that incident RA patients have an increased risk of cardiovascular (CV) mortality relative to the general population in Ontario. Our aim…
Abstract Number: 147 • 2017 ACR/ARHP Annual Meeting
Performance of Cardiovascular Risk Age and Vascular Age Estimations in Predicting Cardiovascular Events in Rheumatoid Arthritis
Grunde Wibetoe¹, Cynthia S. Crowson², Joseph Sexton³, Silvia Rollefstad¹, Eirik Ikdahl¹, George D. Kitas⁴, Piet van Riel⁵, Sherine E. Gabriel⁶, Tore K. Kvien⁷, Karen Douglas⁸, Aamer Sandoo^8,9, Elke Arts⁵, Solveig Wållberg-Jonsson¹⁰, Solbritt Rantapää Dahlqvist¹⁰, George Karpouzas¹¹, Patrick H. Dessein^12,13, Linda Tsang¹⁴, Hani El-Gabalawy¹⁵, Carol A Hitchon¹⁵, Virginia Pascual-Ramos¹⁶, Irazu Contreras-Yañez¹⁷, Petros P Sfikakis¹⁸, Evangelia Zampeli¹⁹, Miguel Angel González-Gay²⁰, Alfonso Corrales²¹, Iris J. Colunga-Pedraza²², Dionicio A. Galarza-Delgado²³, Jose Ramon Azpiri-Lopez²⁴ and Anne Grete Semb¹, ¹Preventive Cardio-Rheuma clinic, Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²Department of Medicine, Division of Rheumatology,Mayo Clinic, Rochester, MN, ³Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁴School of Sport, Exercise and Rehabilitation, University of Birmingham, Birmingham, United Kingdom, ⁵Department of Rheumatic Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ⁶Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, ⁷NORDMARD, Oslo, Norway, Oslo, Norway, ⁸Dudley Group NHS Foundation Trust, West Midlands, United Kingdom, ⁹School of Sport, Health and Exercise Sciences, Bangor University, Bangor, United Kingdom, ¹⁰University of Umeå, Umeå, Sweden, ¹¹Division of Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, ¹²Vrije Universiteit Brussel, Brussel, Belgium, ¹³Universitair Ziekenhuis Brussel, Brussel, Belgium, ¹⁴Rheumatology, Universitair Ziekenhuis Brussel, Brussels, Belgium, ¹⁵University of Manitoba, Winnipeg, MB, Canada, ¹⁶Instituto Nacional de Ciencias Médicas y Nutrició, Mexico City, Mexico, ¹⁷Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ¹⁸First Department of Propedeutic Internal Medicine, Laikon Hospital, Athens University Medical School, Athens, Greece, ¹⁹Institute of Autoimmune Systemic and Neurological Diseases, National and Kapodistrian University of Athens, Athens, Greece, ²⁰Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Johannesburg, South Africa, ²¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²²Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, ²³Chief of Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, ²⁴Cardiology, Hospital Universitario, UANL., Monterrey, Mexico
Background/Purpose: Rheumatoid arthritis (RA) patients are at high risk of cardiovascular disease (CVD). Risk algorithms for the general population lack precision when applied to RA…
Abstract Number: 148 • 2017 ACR/ARHP Annual Meeting
Lack of Screening By Rheumatologists and Primary Care Physicians for Childhood Sexual Abuse in Patients with Fibromyalgia-Depression Overlap: An Unrecognized Crisis?
M. Anthony Albornoz¹, Christian Albornoz² and Daniel J. Clauw³, ¹Rheumatology, Riddle Memorial Hospital/Mainline Health System, Media, PA, ²Temple University School of Medicine, Philadelphia, PA, ³Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI
Background/Purpose: Depression is reported in as many as 71% of patients with Fibromyalgia (FM). An association between Childhood Sexual Abuse (CSA) and FM has been…
Abstract Number: 149 • 2017 ACR/ARHP Annual Meeting
Effect of Vitamin D Supplementation in Chronic Widespread Pain: A Systematic Review and Meta-Analysis
Wai Chung Yong, Anawin Sanguankeo and Sikarin Upala, Bassett Medical Center, Cooperstown, NY
AbstractBackground/Purpose: Chronic non-specific widespread pain (CWP) including fibromyalgia (FM) is characterized by widespread pain, reduced pain threshold and multiple tender points on examination, causing disability…
Abstract Number: 150 • 2017 ACR/ARHP Annual Meeting
Effects of Taping Therapy in the Management of Fibromyalgia: A Randomized Controlled Study
Hae Joo Suh¹ and Sang Tae Choi², ¹Seoul National University Hospital, Seoul, Korea, Republic of (South), ²Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea, Republic of (South)
Background/Purpose: Fibromyalgia is a medical condition characterized by chronic widespread musculoskeletal pain, accompanied by fatigue, insomnia, cognitive problems, psychiatric symptoms and various somatic symptoms. While…
Abstract Number: 151 • 2017 ACR/ARHP Annual Meeting
Prevalence of Fibromyalgia in Nurses; A Cross Sectional Study
Sarah Alajmi¹, Faisal Shahwan¹, Yazeed Bajuaifer¹, Rand Al Ohaly², Maha Edrees², Alanood Asiri² and Mohammed Omair³, ¹Internal Medicine, King Saud University Medical City, Riyadh, Saudi Arabia, ²King Saud University Medical City, Riyadh, Saudi Arabia, ³Division of Rheumatology, Department of Medicine, King Saud University, Riyadh, Saudi Arabia
Background/Purpose: Nurses are at increased of developing pain sensitization syndromes due to stress and interrupted sleep. The prevalence of fibromyalgia (FM) in nurses is unknown.…
Abstract Number: 152 • 2017 ACR/ARHP Annual Meeting
Patients Failing to Fulfill 2016 Criteria for Fibromyalgia Represent a Truly Different Population Subset
Marco Antivalle^1,2, Maria Chiara Ditto³, Alberto Batticciotto³, Rossella Talotta³, Maria Chiara Gerardi³, Alessandra Mutti³, Fabiola Atzeni³ and Piercarlo Sarzi-Puttini³, ¹Rheumatology, Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy, ²Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milan, Italy, ³Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy
Background/Purpose: The 2010/2011 fibromyalgia (FMS) diagnostic criteria (1) were recently revised, with the addition of a generalized pain criterion in order to avoid misclassification of…
Abstract Number: 153 • 2017 ACR/ARHP Annual Meeting
Prevalence of Fibromyalgia in Physician in Training; A Cross Sectional Study
Sarah Alobud¹, Nour Alsultan¹, Abeer Alhazzani¹, Yasmin Altymani¹, Muneera Albugami¹, Maha Omair² and Mohammed Omair³, ¹King Saud University, Riyadh, Saudi Arabia, ²Department of Statistics, College of Science, King Saud University, Riyadh, Saudi Arabia, ³Division of Rheumatology, Department of Medicine, King Saud University, Riyadh, Saudi Arabia
Background/Purpose: Physicians in training (PIT) are at increased of developing pain sensitization syndromes due to stress and interrupted sleep. The prevalence of fibromyalgia (FM) in…
Abstract Number: 154 • 2017 ACR/ARHP Annual Meeting
Frequency of Fibromyalgia in Patients with Antiphospholipid Syndrome. a Cross-Sectional Study
Nicole Mouneu Ornelas¹, Laura-Aline Martinez-Martinez², Vijaya Rivera³, Ricardo Alberto Venegas Yañez⁴, Victor Alejandro Escamilla Gomez⁵, Gumaro Acosta Peña⁶, Luis H. Silveira⁷, Angelica Vargas Guerrero³, Luis M. Amezcua-Guerra³ and Manuel Martínez-Lavín³, ¹Internal Medicine, Instituto Nacional de Cardiología - Ignacio Chávez, IGNACIO CHÁVEZ, Mexico, ²Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, TX, Mexico, ³Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, ⁴Reumatologia, Instituto Nacional de Cardiología "Ignacio Chavez", Ciudad de México, Mexico, ⁵Rheumatology, Instituto Nacional de Cardiología - Ignacio Chávez, Mexico City, Mexico, ⁶Instituto Nacional de Cardiología, Ciudad de mexico, Mexico, ⁷Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City DF, Mexico
Background/Purpose: The observation of several cases with coexistent antiphospholipid syndrome (APS) and fibromyalgia led us to this investigation. The objective was to define the frequency…
Abstract Number: 155 • 2017 ACR/ARHP Annual Meeting
Xerostomia in Patients with Fibromyalgia
Nicolas Lloves¹, Anastasia Secco², Virginia Durigan³, Santiago Scarafia², Felix Romanini Sr.⁴ and Marta Mamani⁴, ¹Rheumatology Department, Hospital Rivadavia, Buenos Aires, Argentina, ²Hospital Bernardino Rivadavia, CABA, Argentina, ³Reumatology, Hospital Bernardino Rivadavia, CABA, Argentina, ⁴Hospital Rivadavia, Buenos Aires, Argentina
Background/Purpose: Fibromyalgia (FM) is a rheumatic disease characterized by diffuse, chronic musculoskeletal pain, of non-articular origin, which is evidenced by the palpation of painful points…
Abstract Number: 156 • 2017 ACR/ARHP Annual Meeting
Unexpectedly High Prevalence of Immunoglobulin Deficiency in Fibromyalgia – II
Xavier J. Caro^1,2 and Earl F. Winter², ¹Northridge Hospital Medical Center, Northridge, CA, ²Southern California Fibromyalgia Research and Treatment Center, Northridge, CA
Background/Purpose: We have recently reported that 70% of an unselected FM cohort (n = 107) had subtle laboratory findings of Primary Immune Deficiency (PID),…
Abstract Number: 157 • 2017 ACR/ARHP Annual Meeting
A Systematic Review of the Upper Limb Soft Tissue Comorbidities in Patients with Type 2 Diabetes Mellitus
Michelle C Papandony¹, Anita E Wluka², Ar Kar Aung³, Yuanyuan Wang¹, Sultana Monira Hussain⁴ and Flavia M Cicuttini¹, ¹Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, Australia, ²Australia, Armadale, Australia, ³Department of General Medicine, Alfred Health, Melbourne, Australia, ⁴Monash University, Department of Epidemiology and Preventative Medicine, Melbourne, Australia
Background/Purpose: Soft tissue disorders affecting the upper limb are not commonly thought of as “classic” complications of type 2 diabetes mellitus. However, the majority of…
Abstract Number: 158 • 2017 ACR/ARHP Annual Meeting
Is Lu Eight-Brocades Exercise Beneficial for Patients with Fibromyalgia?
Juan Jiao¹, Irwin Jon Russell², Wen Wang³, Ya-yun Zhao⁴, Rou-man Zhang⁴, Jing Wang⁴ and Quan Jiang⁵, ¹Rheumatism Department, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China, ²Affiliated with Arthritis & Osteoporosis Center of South Texas, Medical Director, Fibromyalgia Research and Consulting, San Antonio, Texas, San Antonio, TX, ³JCW Education Consulting, Conway, AR, ⁴Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China, ⁵Rheumatology Department, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
Background/Purpose: Fibromyalgia is a chronic debilitating musculoskeletal pain syndrome that causes substantial physical and psychological impairments. With the release of the 2016 revised EULAR recommendations…
Abstract Number: 159 • 2017 ACR/ARHP Annual Meeting
The Use of “Fibromyalgia Rapid Screening Tool” for Detection of Fibromyalgia in Patients with Chronic Arthritis Treated with Full and Tapered Biological Disease-Modifying Antirheumatic Drugs
Larissa Valor¹, Diana Hernández-Flórez², Tamara del Río², Juan Gabriel Ovalles-Bonilla³, Julia Martínez-Barrio⁴, Iustina Janta⁵, Belen Serrano⁶, Claudia Saez⁵, Roberto Gonzalez⁵, Juan Carlos Nieto⁵, Carlos M Gonzalez⁵, Indalecio Monteagudo⁵ and Francisco Javier López Longo⁷, ¹Rheumatology, Hospital general Universitario Gregorio Marañón, Madrid, Spain, ²Rheumatology, Gregorio Marañón University General Hospital, Madrid, Spain, ³Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain, ⁴Servicio de Reumatologia, Hospital General Universitario Gregorio Marañón, Madrid, Spain, ⁵Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, ⁶Rheumatology, Hospital General Universitario Gregorio Marañón, Genoa, Italy, ⁷Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain
Background/Purpose: The coexistence of fibromyalgia (FM) and chronic arthritis is a challenge for an accurate identification of signs and symptoms associated with rheumatoid arthritis (RA),…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].